Researchers have developed a novel approach for delivering small bits of genetic material into the body to improve the treatment of inflammatory bowel diseases. The researchers encapsulated short pieces of RNA into engineered particles called thioketal nanoparticles and orally delivered the genetic material directly to the inflamed intestines of animals.